IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers

Front Immunol. 2022 Oct 3:13:921864. doi: 10.3389/fimmu.2022.921864. eCollection 2022.

Abstract

Immunoglobulin A vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is the most common systemic vasculitis in children, characterized by diverse clinical manifestations with a wide spectrum ranging from isolated cutaneous vasculitis to systemic involvement. The incidence of IgAV is geographically and ethnically variable, with a prevalence in autumn and winter, suggesting a driving role that genetic and environmental factors play in the disease. Although IgAV has a certain degree of natural remission, it varies widely among individuals. Some patients can suffer from severe renal involvement and even progress to end-stage renal disease. Its pathogenesis is complex and has not been fully elucidated. The formation of galactose-deficient IgA1 (Gd-IgA1) and related immune complexes plays a vital role in promoting the occurrence and development of IgAV nephritis. In addition, neutrophil activation is stimulated through the binding of IgA to the Fc alpha receptor I expressed on its surface, resulting in systemic vascular inflammation and tissue damage. Starting from the epidemiological characteristics, this article will review the role of immunological factors such as Gd-IgA1, autoantibodies, circulating immune complexes, complement system, cellular immunization, and the contributions of environmental and genetic factors in the pathogenesis of IgAV, and conclude with the major biomarkers for IgAV.

Keywords: IgA vasculitis; biomarkers; epidemiology; genetic factors; immunopathogenesis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen-Antibody Complex
  • Autoantibodies
  • Biomarkers
  • Child
  • Galactose
  • Humans
  • IgA Vasculitis* / epidemiology
  • Immunoglobulin A
  • Immunologic Factors

Substances

  • Antigen-Antibody Complex
  • Galactose
  • Immunoglobulin A
  • Biomarkers
  • Immunologic Factors
  • Autoantibodies